Shilpa Medicare Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SHILPA MEDICARE, and what generic and branded alternatives to SHILPA MEDICARE drugs are available?
SHILPA MEDICARE has one approved drug.
There are two tentative approvals on SHILPA MEDICARE drugs.
Summary for Shilpa Medicare
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
| Patent Litigation for Shilpa Medicare: | See patent lawsuits for Shilpa Medicare |
Drugs and US Patents for Shilpa Medicare
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shilpa Medicare | AZACITIDINE | azacitidine | POWDER;INTRAVENOUS, SUBCUTANEOUS | 207518-001 | Sep 29, 2016 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
